Tuberculosis, Pulmonary Clinical Trial
Official title:
AI-based System for Lung Tuberculosis Screening: Diagnostic Accuracy Evaluation
Testing of AI solutions to assess diagnostic accuracy for tuberculosis detection.
Status | Active, not recruiting |
Enrollment | 308 |
Est. completion date | December 30, 2023 |
Est. primary completion date | March 15, 2018 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - no pathology in a lung on chest x-ray - signs of lung tuberculosis on chest x-ray Exclusion Criteria: - any pathology in the lungs (except tuberculosis) |
Country | Name | City | State |
---|---|---|---|
Russian Federation | Research and Practical Center of Medical Radiology, Department of Health Care of Moscow | Moscow |
Lead Sponsor | Collaborator |
---|---|
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department |
Russian Federation,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Diagnostic accuracy metric 1 | Sensitivity | Day 1 upon receipt of data | |
Primary | Diagnostic accuracy metric 2 | Specificity | Day 2 upon receipt of data | |
Primary | Diagnostic accuracy metric 3 | Positive predictor values | Day 3 upon receipt of data | |
Primary | Diagnostic accuracy metric 4 | Negative predictor values | Day 4 upon receipt of data | |
Primary | Diagnostic accuracy metric 5 | Likelihood ratio | Day 5 upon receipt of data | |
Primary | Diagnostic accuracy metric 6 | Area under the ROC curve | Day 6 upon receipt of data |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06084715 -
The INSTITUT Study
|
||
Terminated |
NCT03028129 -
Prevention of Tuberculosis in Prisons
|
Phase 4 | |
Not yet recruiting |
NCT06253715 -
Shortened Regimen for Drug-susceptible TB in Children
|
Phase 3 | |
Withdrawn |
NCT03862248 -
Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
|
Phase 3 | |
Completed |
NCT03271567 -
Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients
|
||
Completed |
NCT03199313 -
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid
|
Phase 1 | |
Active, not recruiting |
NCT04919239 -
Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)
|
Phase 2 | |
Active, not recruiting |
NCT03251196 -
TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
|
||
Recruiting |
NCT05926466 -
BTZ-043 Dose Evaluation in Combination and Selection
|
Phase 2 | |
Recruiting |
NCT04752592 -
Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB
|
N/A | |
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Not yet recruiting |
NCT04968886 -
TuBerculosis Viability Interregional Study and Agreement on Biological Tests
|
||
Not yet recruiting |
NCT04485156 -
Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)
|
Phase 3 | |
Active, not recruiting |
NCT02715271 -
Study of TB Lesions Obtained in Therapeutical Surgery
|
||
Completed |
NCT01364324 -
Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients
|
||
Active, not recruiting |
NCT04179500 -
A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis Volunteers
|
Phase 2 | |
Completed |
NCT05899400 -
A Study to Validate and Improve an Automated Image Analysis Algorithm to Detect Tuberculosis in Sputum Smear Slides
|
||
Completed |
NCT04938596 -
Airborne Preventive Measures to Reduce New TB Infections in Household Contacts
|
N/A | |
Recruiting |
NCT05455112 -
Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis
|
Phase 2 | |
Completed |
NCT03044158 -
GeneXpert Performance Evaluation for Linkage to Tuberculosis Care
|
N/A |